AN UNBIASED VIEW OF BMS-199264 HYDROCHLORIDE

Other clinical trials in patients with non-Hodgkin's lymphoma [24] and patients with Sophisticated malignancy [14] have revealed also that zosuquidar didn't appreciably influence the pharmacokinetics of doxorubicin and had moderate consequences to the pharmacokinetics of vincristine. These medical trials accredited that zosuquidar could safely and